CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol. 2012;18(2):203-212.   Published online 2012 June 26    DOI: https://doi.org/10.3350/cmh.2012.18.2.203

Excel Download

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Clinical and Molecular Hepatology. 2012;18(2):203   Crossref logo
Link1 Link2

CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed
Clinical Liver Disease. 2018;11(5):123-127   Crossref logo
Link1 Link2

Low-dose captopril for patients with liver cirrhosis: What is low?
Gastroenterology. 1994;106(4):1131   Crossref logo
Link1 Link2

Continuation of nonselective beta-blockers for patients with liver cirrhosis and hemodynamic nonresponse?
Hepatology. 2017;66(4):1362-1363   Crossref logo
Link1 Link2

Does the dose and type of nonselective beta-blocker really matter?
Hepatology. 2017;66(1):301-302   Crossref logo
Link1 Link2

PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta-blockers outweigh the risks and should be prescribed
Clinical Liver Disease. 2018;11(5):119-122   Crossref logo
Link1 Link2

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
Hepatology. 1999;30(1):79-83   Crossref logo
Link1 Link2

Effects of the beta-blocker, nadolol, on liver hemodynamics and function in patients with liver cirrhosis
Journal of Hepatology. 1985;1:S93   Crossref logo
Link1 Link2

LIVER CIRRHOSIS CAN CHANGE HISTAMINE H2-BLOCKER KINETICS
InPharma. 1982;361(1):12-12   Crossref logo
Link1 Link2 Link3

Stage of cirrhosis predicts the risk of liver-related death in patients with low model for End-Stage liver disease scores and cirrhosis awaiting liver transplantation
Liver Transplantation. 2014;20(10):1193-1201   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.